Adoptive cell transfer and oncolytic virus combination therapy
US11045496B2 · kind B2 · utility
1Cited by
0References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2017 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Jul 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/20243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes a method for treating cancer comprising adoptive transfer of tumor antigen specific CD8+ T cells and an oncolytic virus vaccine targeting the same antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.